Table 3.
Effects of OSA plus dyslipidemia on ASCVD prevalence
| Model | Dyslipidemia + no-OSA | Dyslipidemia + mild-OSA | Dyslipidemia + moderate-OSA | Dyslipidemia + severe-OSA |
|---|---|---|---|---|
| Unadjusted | 1 | 1.54(1.16–2.07)* | 1.77(1.42–2.24)* | 1.96(1.35–2.62)* |
| Mode l | 1 | 1.27(0.89–1.84) | 1.36(1.07–1.86)* | 1.84(1.29–2.33)* |
| Mode 2 | 1 | 1.09(0.81–1.77) | 1.11(0.92–1.75)* | 1.52(1.13–2.02)* |
Denote: *P < 0.05
Model 1 adjusted for age, gender, BMI and waist-hip ratio
Model 2 adjusted for age, gender, BMI, waist-hip ratio, SBP, FPG, LDL-C, CRP and statins